ChemicalsSmall capRs 4,076 crRs 5.6 cr traded a day
Close on 2026-08-21
442.40
−0.17%
52-week range10% of the way up
419.40656.55
Market cap
4,076 cr
P/E (TTM)
7.8×
industry 36×
EPS (TTM)
56.39
Revenue YoY
-2.7%
Q1 FY27
Profit YoY
+32.7%
Net margin
24.7%
+6.6pt vs a year ago
Growth trend
-3.9pt
vs last quarter’s YoY
1 month
+3.0%
Below 52w high
48.4%
RSI (14)
47
Daily swing
1.9%
average true range
Volume
0.5×
vs 20-day average
Traded
Rs 6 cr
median day
Close200-day averageMaterial filing
260 sessions · hover for the filing behind a move
1 week
+3.12%
1 month
+3.00%
3 months
−3.50%
6 months
−10.38%
1 year
−20.91%
The read
written from the numbers on this page
The evidence is mixed4 supporting, 3 against, 2 worth knowing
Supporting
matches near a 52-week low, which has beaten the market by +0.45 points over 20 sessions across 47,393 past signals
3 independent kinds of evidence agree today, which is uncommon
net margin has widened from 14.8% to 24.7% across four quarters
priced at 8× earnings against an industry median of 36× — 78% below its peers
Against
trading 10% below its 200-day average
at 10% of its 52-week range — nearly everyone who bought in the past year is underwater
down 21% over twelve months
Worth knowing
the 50-day and 200-day averages disagree, which usually means a turn in progress rather than a trend to lean on
revenue fell 3% year on year in the quarter ending 2026-06-30
What would change this read: a close back above 490, its 200-day average.
Assembled automatically from the figures on this page — the scans matched, their measured record, the filed financials, the derivatives positioning and the peer comparison. It is not a recommendation, no one has spoken to the company, and every claim above can be checked against a number further down this page.
What is working, what is not
read from the filings, with the figure behind every line
Working3
Net margin moved from 18.1% to 24.7%.
18.1%24.7%
Net profit +32.7% year on year, Rs 144 cr to Rs 191 cr.
+32.7%Rs 144 crRs 191 cr
Profit grew faster than revenue, +32.7% against -2.7%.
+32.7%-2.7%
Needs watching
Nothing in the filings stands out either way.
Every figure here is computed from the company’s own filings. The wording is generated directly from the figures.
How it has performed
price return over each window, measured against zero
What the scans say today
3 of 47 matched on 2026-08-21
GHCL matches 3 of the 47 scans today, across 3 different kinds of evidence. Three or more independent families agreeing is uncommon — it is the same test the shortlist on every page uses.
GHCL trades at 8× trailing earnings, below its median of 9× over this window — 15% less expensive than usual. The band runs from the 5th to the 95th percentile, so single-day spikes do not set the edges.
This window is short by the standards of valuation history — it begins where four quarters of filed earnings first exist. A stock can look cheap against two years and expensive against ten.
Order win filings were typically +0.20pt vs the market over the next 5 sessions (n=408) · Analyst call filings were typically +0.14pt vs the market over the next 5 sessions (n=3,352) · Other filing filings were typically -0.08pt vs the market over the next 5 sessions (n=12,093)
The business
from the company’s filed results
Everything below is taken from the company’s own quarterly filing with the exchange — the XBRL document it submitted, not a vendor’s summary of it. Figures in rupees crore.
RevenueNet profit, drawn inside its revenue barNet margin, own scale belowrupees crore, per quarter as filed. Revenue bars start at zero.
Going for it
profit rose 33% year on year
net margin widened from 14.6% to 24.7%
Going against it
revenue fell 3% against the same quarter a year earlier
Quarter-by-quarter numbers, as filed
Quarter
Revenue
Profit before tax
Net profit
EPS
Net margin
Q1 FY27
2026-06-30 · standalone
774
258
191
21.04
24.7%
Q4 FY26
2026-03-31 · consolidated
791
160
116
12.28
14.6%
Q3 FY26
2025-12-31 · consolidated
757
143
106
11.26
14.0%
Q2 FY26
2025-09-30 · consolidated
721
145
107
11.16
14.8%
Q1 FY26
2025-06-30 · consolidated
796
195
144
15.10
18.1%
Q4 FY25
2025-03-31 · consolidated
781
209
150
15.72
19.2%
Quarterly filings are unaudited unless stated. Consolidated figures are used where the company files both. A single quarter is a noisy thing — the trend across the column is worth more than the top row.
Where the price stands
the same figures every scan on this site is computed from
Trend
Distance from the averages traders watch. Above all of them is a bull phase; below the 200-day is the line most investors use to say otherwise.
Versus 50-day average+1.4%
Versus 200-day average-9.8%
Below 52-week high-32.6%
Above 52-week low+5.5%
Momentum
How hard it has been pushed lately. Above 70 on RSI is stretched, below 30 is washed out — neither is a signal on its own.
RSI (14)47.5
Higher closes in last 53 of 5
Six-month return−10.38%
Risk and liquidity
What a position costs to hold and to exit. Position sizing starts with the daily swing, not with conviction.
Typical daily swing (ATR)1.91%
Volume versus 20-day0.5x
Median daily turnoverRs 5.6 cr
Peers
Chemicals · 44 classified companies
GHCL trades at 7.8× trailing earnings against an industry median of 36.0× across 41 other classified companies in its industry — cheaper than them, by 78%. A multiple is a statement about expectations, not about quality: cheap usually means the market expects less, and it is often right.